Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) announces the appointment of. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while ...
12d
The merger of UBS and Credit Suisse presented a significant challenge: the seamless integration of Credit Suisse’s open legal matters and external law firms into UBS’s legal operations. To address ...
added Brian Clark, Vice President, Global Medical Head of Gastro-Enterology Therapeutic Area, Global Research and Medical, Ferring.
Thank you for signing up! Did you know with an ad-lite subscription to SussexWorld, you get 70% fewer ads while viewing the news that matters to you. Sorry, there ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical ...
DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix ...
However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...
The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...
NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...
DUBLIN, Feb. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in TD Cowen's 45 th Annual Health Care Conference. Company ...
Pegylation has taken 20 years to emerge as a viable pharmaceutical tool. During this time there have been important advances in the chemistry of pegylation, in the generation of biomolecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback